EPAS1 and pulmonary arterial hypertension: Similarly, eight separate cases of erythrocytosis linked to novel hereditary heterozygous HIF2α, gain-of-function mutations, M535V/I, G537W, and D539E, did not present with PAH or PH (48–50).